Skip to main content

Table 1 Patient demographics

From: Isoflurane vs. propofol for sedation in invasively ventilated patients with acute hypoxemic respiratory failure: an a priori hypothesis substudy of a randomized controlled trial

Variable

Category

Isoflurane (n = 72)

Propofol (n = 90)

Total (n = 162)

p (isoflurane vs. propofol)

Age (yrs)

Mean (± SD)

66 (± 11)

65 (± 12)

65.5 (± 12)

0.585

Min/Max

32/87

33/92

32/92

 

Sex

F

19 (26.4%)

29 (32.2%)

48 (29.6%)

n.a

M

53 (73.6%)

61 (67.8%)

114 (70.4%)

 

Height (cm)

Mean (± SD)

174 (± 9)

173 (± 9)

174 (± 9)

1.000

Min/Max

148/200

155/198

148/200

 

Weight (kg)

Mean (± SD)

89 (± 22)

88 (± 24)

88 (± 23)

0.785

Min/Max

50/148

52/170

50/170

 

BMI (kg/m2)

Mean (± SD)

29.2 (± 6.9)

29.3 (± 8.0)

29.3 (± 7.5)

0.933

Min/max

15.4/55.7

16.9/63.2

15.4/63.2

 

SAPS II

Mean

47 ± 14 (n = 58)

45 ± 18 (n = 71)

46 ± 16 (n = 129)

0.490

Min/max

14/86

13/88

13/88

 

SOFA

Mean (± SD)

10.6 (± 3.4)

10.3 (± 3.3)

10.4 (± 3.3)

0.571

Min/max

2/18

2/16

2/18

 

PaO2/FiO2 (mmHg)

Mean (± SD)

199 (± 58)

202 (± 62)

200.5 (± 60)

0.753

Min/max

84/298

70/298

70/298

 

Main Reason for ICU Admission

Medical

Neurosurgical

35 (48.6%)

1 (1.4%)

43 (47.8%)

0

78 (48.1%)

1 (0.6%)

n.a

Surgical

Trauma

33 (45.8%)

3 (4.2%)

41 (45.6%)

6 (6.7%)

74 (45.7%)

9 (5.6%)

 
  1. BMI body mass index, SAPS II Simplified Acute Physiology Score, SOFA Sequential Organ Failure Assessment, N.a. not available